Abstract

Arrhythmogenic right ventricular dysplasia (ARVD) is a rare genetic condition of the myocardium, with a significantly high risk of sudden death. Recent genetic research and improved understanding of the pathophysiology tend to change the ARVD definition towards a larger spectrum of myocardial involvement, which includes, in various proportions, both the right (RV) and left ventricle (LV), currently referred to as ACM (arrhythmogenic cardiomyopathy). Its pathological substrate is defined by the replacement of the ventricular myocardium with fibrous adipose tissue that further leads to inadequate electrical impulses and translates into varies degrees of malignant ventricular arrythmias and dyskinetic myocardium movements. Particularly, the cardio-cutaneous syndromes of Carvajal/Naxos represent rare causes of ACM that might be suspected from early childhood. The diagnostic is sometimes challenging, even with well-established rTFC or Padua criteria, especially for pediatric patients or ACM with LV involvement. Cardiac MRI gain more and more importance in ACM diagnostic especially in non-classical forms. Furthermore, MRI is useful in highlighting myocardial fibrosis, fatty replacement or wall movement with high accuracy, thus guiding not only the depiction, but also the patient’s stratification and management.

Highlights

  • Arrhythmogenic right ventricular dysplasia (ARVD) is a genetic condition of the myocardium, clinically characterized through syncope, malignant ventricular arrhythmias and sudden death

  • Recent genetic research and improved understanding of the pathophysiology tend to change the ARVD definition towards a larger spectrum of myocardial involvement, which includes, in various proportions, both the right (RV) and left ventricle (LV), currently referred to as ACM

  • According to the database of the anatomical variants of the ARVC (The ARVC Genetic Variants Database), in the last two decades more than 1400 variants of the 12 genes involved in ACM have been discovered, as follows: plakophilin (PKP2), desmoplakin (DSP), desmochollin (DSC2), desmoglein (DSG2), plakoglobin (JUP), transforming growth factor (TGFG3), transmembrane protein 43 (TMEM43), A/C lamina (LMNA), desmin (DES), titin (TTN), phospholamban (PLN), catenin alpha-3 (CTNNA3)

Read more

Summary

Introduction

Arrhythmogenic right ventricular dysplasia (ARVD) is a genetic condition of the myocardium, clinically characterized through syncope, malignant ventricular arrhythmias and sudden death. ARVD is a rare condition, with a prevalence of 1:2000–1:5000 [1], more often encountered in young patients and athletes. Due to recent research and an improved understanding of the genetic substrate [1,2,3,4,5] the definition refers to a larger spectrum of myocardial involvement, which includes, in various proportions, both the right ventricle (RV) and the left ventricle (LV). The diagnostic is sometimes challenging, even with well-established rTFC or Padua criteria, especially for pediatric patients or ACM with LV involvement. The Padua system was developed to assess the involvement of LV based on new criteria, including MRI features. MRI is useful in highlighting myocardial fibrosis, fatty replacement or wall movement with high accuracy, guiding the depiction, and the patient’s stratification and management

Genetics
Pathophysiology
MRI Diagnostic Criteria
Differential Diagnosis—Normal Variants
Differential Diagnosis—Pathologic Conditions
Cases Presentation First patient
Findings
Discussion
Conclusions
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.